Elite in Hemolysis

Bart J. Biemond

St. Antonius Ziekenhuis, 
Nieuwegein, UT, NL 
Elite in Hemolysis
St. Antonius Ziekenhuis, 
Nieuwegein, UT, NL 
OverviewLocationsClinical Research

Overview

Bart Biemond practices in Nieuwegein, Netherlands. Mr. Biemond is rated as an Elite expert by MediFind in the treatment of Hemolysis. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Anemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 166 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Hemolysis.

Gender
Male

Locations

St. Antonius Ziekenhuis, Nieuwegein, UT, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety of Human Apotransferrin in Patients With β-thalassemia Intermedia
Efficacy and Safety of Human Apotransferrin in Patients With β-thalassemia Intermedia
Enrollment Status: Terminated
Publish Date: August 15, 2022
Intervention Type: Biological
Study Drug: Apotransferrin
Study Phase: Phase 2
A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Investigate Efficacy and Safety of Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects With Sickle-Cell Disease (SCD).
A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Investigate Efficacy and Safety of Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects With Sickle-Cell Disease (SCD).
Enrollment Status: Completed
Publish Date: July 16, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
View 1 Less Clinical Trial

166 Total Publications

Clinical burden and healthcare resource utilization of patients with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta-thalassemia in the Netherlands.
Clinical burden and healthcare resource utilization of patients with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta-thalassemia in the Netherlands.
Journal: Current medical research and opinion
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Biemond's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile